Skip to content

A prospective randomized controlled study of single and double pulse width pulsed dye laser in the treatment of post-burn hypertrophic scars

A prospective randomized controlled study of single and double pulse width pulsed dye laser in the treatment of post-burn hypertrophic scars

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050689
Enrollment
Unknown
Registered
2021-09-02
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Scar

Interventions

Experimental group1:single short pulse width treatment
Experimental group2:single long pulse width treatment
Experimental group3:dual(short - long) pulse width treatment
Experimental group4:dual (long - short) pulse width treatment

Sponsors

The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Healthy male or female aged 18 to 65 years; 2. Patients with hypertrophic scar after deep second-degree burns; 3. Non-facial scars and <= 3 months; 4. Understand and be willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Laser treatment for scars in the past; 2. Patients diagnosed with keloid; 3. Patients who have been diagnosed with scar constitution; 4. Patients with systemic or local recurrent eczema; 5. Use of photosensitivity drugs within 6 months; 6. The treatment area is accompanied by severe skin disease or inflammatory skin disease; 7. According to the clinical judgment of the investigator, participate in other equipment research or drug research within 30 days before enrollment; 8. The patient's physical or mental state is unstable; 9. Those planning to become pregnant within 3 months, pregnant and/or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Scar hyperplasia rate;

Secondary

MeasureTime frame
Improvement rate of cicatricial itching;Scar vascular improvement rate;

Countries

China

Contacts

Public ContactLi Na

The First Affiliated Hospital of Air Force Medical University

linaxjss@163.com+86 18710931036

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026